📋 Case Study
Pharmaceutical Batch Hydrogenation Process Intensification
Poor mass transfer limiting reaction rate; inconsistent enantioselectivity above 50 L scale
🏗️ Project Overview
API manufacturing facility in Ireland scaling from 10 L to 200 L hydrogenation reactor
🎯 Challenge
Poor mass transfer limiting reaction rate; inconsistent enantioselectivity above 50 L scale
🔧 Design Approach
Combined kinetic + gas-liquid mass transfer modeling (k_La estimation); impeller redesign and H₂ partial pressure optimization
📐 Design Diagram
AI-generated project design illustration
📐 Key Calculations
Volumetric Mass Transfer Coefficient (k_La)
k_La = (1/V_L) * dC_L/dt
Result: 0.021 s⁻¹ @ 10 L, 0.008 s⁻¹ @ 200 L
Identified scale-dependent limitation
Hydrogen Availability Index (HAI)
HAI = (k_La * C*_H2) / (-r_H2)
Result: 1.2 @ small scale, 0.6 @ large scale
HAI < 1 indicates H₂ starvation
Enantiomeric Excess (ee) Sensitivity
∂(ee)/∂(H₂ pressure)
Result: 0.8 %ee/bar
Guided precise pressure control strategy
📊 Results
Reaction time reduced by 40%, ee maintained >99.5% across scales, eliminated off-spec batches💡 Lessons Learned
- •Kinetic selectivity is highly sensitive to local H₂ concentration gradients—not bulk pressure
- •Impeller type (Rushton vs. A310) dominates k_La more than speed above critical power input
- •In-line PAT (FTIR) enabled real-time endpoint detection and adaptive dosing
✅ Key Takeaways
- 1Kinetic selectivity is highly sensitive to local H₂ concentration gradients—not bulk pressure
- 2Impeller type (Rushton vs. A310) dominates k_La more than speed above critical power input
- 3In-line PAT (FTIR) enabled real-time endpoint detection and adaptive dosing